Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.

Bowman P, Sulen Å, Barbetti F, Beltrand J, Svalastoga P, Codner E, Tessmann EH, Juliusson PB, Skrivarhaug T, Pearson ER, Flanagan SE, Babiker T, Thomas NJ, Shepherd MH, Ellard S, Klimes I, Szopa M, Polak M, Iafusco D, Hattersley AT, Njølstad PR, Neonatal Diabetes International Collaborative Group

Open source

DOI
10.1016/s2213-8587(18)30106-2
Published
2018 Aug
Container
The lancet. Diabetes & endocrinology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2213-8587-18-30106-2,
  title = {Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.},
  author = {Bowman P and Sulen Å and Barbetti F and Beltrand J and Svalastoga P and Codner E and Tessmann EH and Juliusson PB and Skrivarhaug T and Pearson ER and Flanagan SE and Babiker T and Thomas NJ and Shepherd MH and Ellard S and Klimes I and Szopa M and Polak M and Iafusco D and Hattersley AT and Njølstad PR and Neonatal Diabetes International Collaborative Group},
  year = {2018},
  journal = {The lancet. Diabetes \& endocrinology},
  doi = {10.1016/s2213-8587(18)30106-2},
  url = {https://doi.org/10.1016/s2213-8587(18)30106-2}
}

RIS

TY  - JOUR
TI  - Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.
AU  - Bowman P
AU  - Sulen Å
AU  - Barbetti F
AU  - Beltrand J
AU  - Svalastoga P
AU  - Codner E
AU  - Tessmann EH
AU  - Juliusson PB
AU  - Skrivarhaug T
AU  - Pearson ER
AU  - Flanagan SE
AU  - Babiker T
AU  - Thomas NJ
AU  - Shepherd MH
AU  - Ellard S
AU  - Klimes I
AU  - Szopa M
AU  - Polak M
AU  - Iafusco D
AU  - Hattersley AT
AU  - Njølstad PR
AU  - Neonatal Diabetes International Collaborative Group
PY  - 2018
JO  - The lancet. Diabetes & endocrinology
DO  - 10.1016/s2213-8587(18)30106-2
UR  - https://doi.org/10.1016/s2213-8587(18)30106-2
ER  - 

APA

P, B., Å, S., F, B., J, B., P, S., E, C., EH, T., PB, J., T, S., ER, P., SE, F., T, B., NJ, T., MH, S., S, E., I, K., M, S., M, P., D, I., AT, H., PR, N., & Group, N. D. I. C. (2018). Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.. The lancet. Diabetes & endocrinology. https://doi.org/10.1016/s2213-8587(18)30106-2

Source records